U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022496

Expand all

EXPAREL (BUPIVACAINE)
133MG/10ML (13.3MG/ML)
Marketing Status: Prescription
Active Ingredient: BUPIVACAINE
Proprietary Name: EXPAREL
Dosage Form; Route of Administration: INJECTABLE, LIPOSOMAL; INJECTION
Strength: 133MG/10ML (13.3MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N022496
Product Number: 001
Approval Date: Oct 28, 2011
Applicant Holder Full Name: PACIRA PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
EXPAREL (BUPIVACAINE)
266MG/20ML (13.3MG/ML)
Marketing Status: Prescription
Active Ingredient: BUPIVACAINE
Proprietary Name: EXPAREL
Dosage Form; Route of Administration: INJECTABLE, LIPOSOMAL; INJECTION
Strength: 266MG/20ML (13.3MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N022496
Product Number: 002
Approval Date: Oct 28, 2011
Applicant Holder Full Name: PACIRA PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top